CAPRICOR THERAPEUTICS, INC. (CAPR) Stock Forecast 2025 - AI Price Prediction & Analysis

Q: What factors influence CAPRICOR THERAPEUTICS, INC. stock price forecasts?

Our analysis considers financial metrics, sector trends, market sentiment, technical indicators, and macroeconomic factors.

CAPRICOR THERAPEUTICS, INC. (CAPR) AI Stock Price Forecast & Investment Analysis

Latest Analysis Date: July 17, 2025

Loading CAPRICOR THERAPEUTICS, INC. interactive price chart and technical analysis...

CAPRICOR THERAPEUTICS, INC. (CAPR) - Comprehensive Stock Analysis & Investment Research

Deep dive into CAPRICOR THERAPEUTICS, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about CAPRICOR THERAPEUTICS, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For CAPRICOR THERAPEUTICS, INC.: CAPRICOR THERAPEUTICS, INC. operates in the Life Sciences sector, making it an emerging small-cap investment.

CAPRICOR THERAPEUTICS, INC. (Stock Symbol: CAPR) is a leading company in the Life Sciences sector , specifically operating within the Pharmaceutical Preparations industry.

The organization employs approximately 73 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing CAPRICOR THERAPEUTICS, INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CAPRICOR THERAPEUTICS, INC.: With $23M in annual revenue and -146.9% net margin, the company demonstrates developing profitability.

Annual Revenue: $23 million generating a -146.9% net profit margin .

Market Capitalization: $327 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -74.4% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for CAPRICOR THERAPEUTICS, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For CAPRICOR THERAPEUTICS, INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CAPRICOR THERAPEUTICS, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: CAPRICOR THERAPEUTICS, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For CAPRICOR THERAPEUTICS, INC.: Strong free cash flow generation demonstrates developing operational efficiency.

CAPRICOR THERAPEUTICS, INC. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $9 million annually.

The company maintains a healthy 100.0% gross margin, indicating strong pricing power and operational efficiency.

CAPRICOR THERAPEUTICS, INC. (CAPR) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CAPRICOR THERAPEUTICS, INC. stock analysis.

Loading CAPRICOR THERAPEUTICS, INC. comprehensive fundamental analysis and insider trading data...

Deep dive into CAPRICOR THERAPEUTICS, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if CAPRICOR THERAPEUTICS, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For CAPRICOR THERAPEUTICS, INC.: With a P/E ratio of -14.07, the market sees the stock as potentially undervalued.

P/E Ratio -14.07x

P/B Ratio 2.56x

Market Cap $327M

EPS $-1.02

Book Value/Share $2.79

Revenue/Share $-0.51

FCF/Share $-0.71

Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently CAPRICOR THERAPEUTICS, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CAPRICOR THERAPEUTICS, INC.: An ROE of -74.4% indicates room for improvement in shareholder value creation.

ROE -74.4%

ROA -41.8%

ROIC -70.7%

Gross Margin 100.0%

Operating Margin -155.6%

Net Margin -146.9%

EBT Margin -760.4%

Understanding Financial Health Metrics

What these metrics mean: These ratios assess CAPRICOR THERAPEUTICS, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For CAPRICOR THERAPEUTICS, INC.: A current ratio of 4.16 indicates strong liquidity.

Current Ratio 4.16x

Quick Ratio 4.10x

D/E Ratio 0.09x

Financial Leverage 2.63x

Interest Coverage 7.1x

Working Capital $31M

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal CAPRICOR THERAPEUTICS, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For CAPRICOR THERAPEUTICS, INC.: Free cash flow of $9M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $11M

Free Cash Flow $9M

Capital Spending $-2M

FCF/Sales -678.7%

CapEx/Sales 874.5%

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively CAPRICOR THERAPEUTICS, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For CAPRICOR THERAPEUTICS, INC.: An asset turnover of 0.01x suggests room for improvement in asset utilization.

Asset Turnover 0.01x

Receivables Turnover 0.6x

Fixed Assets Turnover 0.1x

Days Sales Outstanding 638 days

Understanding Financial Statement Data

What these metrics mean: Key figures from CAPRICOR THERAPEUTICS, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For CAPRICOR THERAPEUTICS, INC.: With annual revenue of $23M, CAPRICOR THERAPEUTICS, INC. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)

Total Revenue $23M

Operating Income $-36M

Net Income $-34M

R&D Expense $45M

SG&A Expense $358M

Cost of Goods Sold $-44M

Balance Sheet Highlights (% Of Assets)

Total Current Assets 92%

Cash & Short-term Investments 90%

Total Liabilities 62%

Short-term Debt 1%

Accounts Receivable 1%

Dividend & Shareholder Information

Shares Outstanding 46M

Growth Metrics (YoY)

EPS Growth -6.8%

Latest CAPRICOR THERAPEUTICS, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting CAPRICOR THERAPEUTICS, INC. (CAPR) stock price and investment outlook.

Capricor Therapeutics Responds to FDA Posting of Complete Response Letter (CRL) for Deramiocel

5h ago, source: Markets Insider

However, the FDA did not release the comprehensive preliminary response that Capricor submitted shortly after receipt of the CRL. This written response provided clarifications to the Agency’s feedback ...

Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) largest shareholders are retail investors with 58% ownership, institutions own 30%

1d ago, source: Yahoo Finance

A look at the shareholders of Capricor Therapeutics, Inc. (NASDAQ:CAPR) can tell us which group is most powerful. The group holding the most number of shares in the company, around 58% to be precise, ...

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR

1d ago, source: The Globe and Mail

Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.

CAPR INVESTOR ALERT: Kirby McInerney LLP Notifies Capricor Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

1d ago, source: None

Kirby McInerney LLP reminds Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) investors of the September 15, 2025 deadline to seek the role of lead plaintiff in a pending ...

Class Action Lawsuit Filed Against Capricor Therapeutics, Inc. (CAPR) - Recover Losses - Contact Levi & Korsinsky Before September 15, 2025

1d ago, source: The Globe and Mail

Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics

5h ago, source: None

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR).

Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher

11mon ago, source: Benzinga.com

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like Duchenne muscular dystrophy (DMD).

Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Fraud ...

2mon ago, source: Morningstar

Shares of Capricor Therapeutics, Inc. plunged over 30% in intraday trading on Friday, July 11, 2025, after the U.S. Food and Drug Administration rejected the company’s Biologics License ...

Investors who lost money on Capricor Therapeutics, Inc. (CAPR) should ...

1mon ago, source: Morningstar

Investors who lost money on Capricor Therapeutics, Inc. (CAPR) should contact Levi & Korsinsky about pending Class Action - CAPR Provided by GlobeNewswire Jul 25, 2025, 1:38:00 PM ...

Capricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q1 2022 Results ...

3y ago, source: Seeking Alpha

Capricor Therapeutics, Inc. (NASDAQ: CAPR) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Anthony Bergmann - CFO & Corporate Treasurer Linda Marban - Co-Founder ...

Brokerages Set Capricor Therapeutics Inc (NASDAQ:CAPR) Price Target at ...

6mon ago, source: ETF Daily News

Capricor Therapeutics Inc (NASDAQ:CAPR – Get Free Report) has received a consensus recommendation of “Buy” from the six research firms that are currently covering the stock, Marketbeat.com ...

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Contact Levi ...

23d ago, source: KTLA

NEW YORK, NY / ACCESS Newswire / August 17, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the ...

CAPRICOR THERAPEUTICS, INC. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of CAPRICOR THERAPEUTICS, INC. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company	Ticker Symbol	90-Day AI Forecast	Market Cap (USD M)	P/E Ratio	P/B Ratio
Whitehawk Therapeutics, Inc.	AADI	Unlock Forecast - 30 Days FREE Trial	$83M	-1.0x	1.6x
Aardvark Therapeutics, Inc.	AARD	Unlock Forecast - 30 Days FREE Trial	$187M	x	1.4x
AbbVie Inc.	ABBV	Unlock Forecast - 30 Days FREE Trial	$0M	57.5x	0.0x
AbCellera Biologics Inc.	ABCL	Unlock Forecast - 30 Days FREE Trial	$1239M	-5.3x	1.2x
ABEONA THERAPEUTICS INC.	ABEO	Unlock Forecast - 30 Days FREE Trial	$339M	-2.5x	8.2x
ABBOTT LABORATORIES	ABT	Unlock Forecast - 30 Days FREE Trial	$231225M	16.5x	4.6x
Arbutus Biopharma Corp	ABUS	Unlock Forecast - 30 Days FREE Trial	$805M	-8.3x	9.7x
ABVC BIOPHARMA, INC.	ABVC	Unlock Forecast - 30 Days FREE Trial	$56M	-0.3x	10.3x
ACADIA PHARMACEUTICALS INC	ACAD	Unlock Forecast - 30 Days FREE Trial	$4281M	19.3x	5.2x
Adicet Bio, Inc.	ACET	Unlock Forecast - 30 Days FREE Trial	$66M	-0.4x	0.5x
Aclaris Therapeutics, Inc.	ACRS	Unlock Forecast - 30 Days FREE Trial	$257M	-4.5x	2.0x
Acrivon Therapeutics, Inc.	ACRV	Unlock Forecast - 30 Days FREE Trial	$51M	-2.8x	0.4x
ACTUATE THERAPEUTICS, INC.	ACTU	Unlock Forecast - 30 Days FREE Trial	$165M	x	-24.1x
Accustem Sciences Inc.	ACUT	Unlock Forecast - 30 Days FREE Trial	$32M	x	x
Acurx Pharmaceuticals, Inc.	ACXP	Unlock Forecast - 30 Days FREE Trial	$6M	-0.8x	1.7x
Adagene Inc.	ADAG	Unlock Forecast - 30 Days FREE Trial	$130M	x	3.4x
ADC Therapeutics SA	ADCT	Unlock Forecast - 30 Days FREE Trial	$398M	-9.2x	-1.3x
ADIAL PHARMACEUTICALS, INC.	ADIL	Unlock Forecast - 30 Days FREE Trial	$8M	-0.1x	1.4x
Aditxt, Inc.	ADTX	Unlock Forecast - 30 Days FREE Trial	$3M	0.0x	0.2x
AEON Biopharma, Inc.	AEON	Unlock Forecast - 30 Days FREE Trial	$9M	0.2x	-0.8x
AGIOS PHARMACEUTICALS, INC.	AGIO	Unlock Forecast - 30 Days FREE Trial	$2118M	3.3x	1.6x
Ainos, Inc.	AIMD	Unlock Forecast - 30 Days FREE Trial	$15M	-0.4x	1.3x
Ainos, Inc.	AIMDW	Unlock Forecast - 30 Days FREE Trial	$1M	x	0.0x
Akebia Therapeutics, Inc.	AKBA	Unlock Forecast - 30 Days FREE Trial	$1014M	-5.4x	41.2x
Akero Therapeutics, Inc.	AKRO	Unlock Forecast - 30 Days FREE Trial	$3574M	-8.7x	3.5x
Akari Therapeutics Plc	AKTX	Unlock Forecast - 30 Days FREE Trial	$53423M	-2.0x	2086.4x
Aldeyra Therapeutics, Inc.	ALDX	Unlock Forecast - 30 Days FREE Trial	$338M	-5.1x	6.1x
Alkermes plc.	ALKS	Unlock Forecast - 30 Days FREE Trial	$4842M	17.4x	3.2x
Allakos Inc.	ALLK	Unlock Forecast - 30 Days FREE Trial	$30M	-0.5x	0.5x
Allarity Therapeutics, Inc.	ALLR	Unlock Forecast - 30 Days FREE Trial	$29M	-0.2x	2.4x
ALUMIS INC.	ALMS	Unlock Forecast - 30 Days FREE Trial	$295M	x	0.6x
ALNYLAM PHARMACEUTICALS, INC.	ALNY	Unlock Forecast - 30 Days FREE Trial	$59598M	-224.3x	237.8x
Rein Therapeutics, Inc.	ALRN	Unlock Forecast - 30 Days FREE Trial	$43M	-1.4x	0.8x
Altimmune, Inc.	ALT	Unlock Forecast - 30 Days FREE Trial	$322M	-5.7x	2.0x
ALT5 Sigma Corp	ALTS	Unlock Forecast - 30 Days FREE Trial	$114M	-1.7x	4.4x
ALX ONCOLOGY HOLDINGS INC	ALXO	Unlock Forecast - 30 Days FREE Trial	$66M	-0.4x	1.0x
Alzamend Neuro, Inc.	ALZN	Unlock Forecast - 30 Days FREE Trial	$2M	-0.1x	0.5x
Amylyx Pharmaceuticals, Inc.	AMLX	Unlock Forecast - 30 Days FREE Trial	$743M	-1.5x	3.7x
Amphastar Pharmaceuticals, Inc.	AMPH	Unlock Forecast - 30 Days FREE Trial	$983M	13.9x	4.7x
AMARIN CORP PLC\UK	AMRN	Unlock Forecast - 30 Days FREE Trial	$6368M	-4.5x	13.7x
Amneal Pharmaceuticals, Inc.	AMRX	Unlock Forecast - 30 Days FREE Trial	$1303M	385.9x	0.0x
ANAPTYSBIO, INC	ANAB	Unlock Forecast - 30 Days FREE Trial	$811M	-2.5x	23.8x
Anebulo Pharmaceuticals, Inc.	ANEB	Unlock Forecast - 30 Days FREE Trial	$98M	-4.3x	7.3x
ANI PHARMACEUTICALS INC	ANIP	Unlock Forecast - 30 Days FREE Trial	$2061M	103.2x	4.7x
Anixa Biosciences Inc	ANIX	Unlock Forecast - 30 Days FREE Trial	$95M	-15.0x	4.3x
Annexon, Inc.	ANNX	Unlock Forecast - 30 Days FREE Trial	$322M	-4.1x	1.6x
Alto Neuroscience, Inc.	ANRO	Unlock Forecast - 30 Days FREE Trial	$99M	x	0.8x
AN2 Therapeutics, Inc.	ANTX	Unlock Forecast - 30 Days FREE Trial	$33M	-0.7x	0.5x
Annovis Bio, Inc.	ANVS	Unlock Forecast - 30 Days FREE Trial	$52M	-1.0x	2.2x
Apellis Pharmaceuticals, Inc.	APLS	Unlock Forecast - 30 Days FREE Trial	$3396M	-13.6x	21.7x
Applied Therapeutics, Inc.	APLT	Unlock Forecast - 30 Days FREE Trial	$67M	-0.7x	1.8x
Aprea Therapeutics, Inc.	APRE	Unlock Forecast - 30 Days FREE Trial	$9M	-1.2x	0.6x
Apimeds Pharmaceuticals US, Inc.	APUS	Unlock Forecast - 30 Days FREE Trial	$24M	x	2.5x
Aptevo Therapeutics Inc.	APVO	Unlock Forecast - 30 Days FREE Trial	$171M	-0.1x	38.6x
Aquestive Therapeutics, Inc.	AQST	Unlock Forecast - 30 Days FREE Trial	$498M	-10.7x	-6.9x
Arcturus Therapeutics Holdings Inc.	ARCT	Unlock Forecast - 30 Days FREE Trial	$484M	-7.0x	2.1x
ARDELYX, INC.	ARDX	Unlock Forecast - 30 Days FREE Trial	$1576M	-21.3x	11.3x
Arcutis Biotherapeutics, Inc.	ARQT	Unlock Forecast - 30 Days FREE Trial	$1749M	-6.6x	12.3x
ARTELO BIOSCIENCES, INC.	ARTL	Unlock Forecast - 30 Days FREE Trial	$3M	-0.7x	42.0x
ARVINAS, INC.	ARVN	Unlock Forecast - 30 Days FREE Trial	$573M	-4.8x	0.9x
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Unlock Forecast - 30 Days FREE Trial	$3768M	-4.7x	7.2x
Aspire Biopharma Holdings, Inc.	ASBP	Unlock Forecast - 30 Days FREE Trial	$25M	x	x
ASSEMBLY BIOSCIENCES, INC.	ASMB	Unlock Forecast - 30 Days FREE Trial	$183M	-1.5x	10.1x
Assertio Holdings, Inc.	ASRT	Unlock Forecast - 30 Days FREE Trial	$77M	-0.2x	0.8x
ATAI Life Sciences N.V.	ATAI	Unlock Forecast - 30 Days FREE Trial	$961M	-4.4x	6.7x
180 Life Sciences Corp.	ATNF	Unlock Forecast - 30 Days FREE Trial	$2M	-0.1x	0.6x
180 Life Sciences Corp.	ATNFW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Actinium Pharmaceuticals, Inc.	ATNM	Unlock Forecast - 30 Days FREE Trial	$42M	-4.1x	1.6x
ATOSSA THERAPEUTICS, INC.	ATOS	Unlock Forecast - 30 Days FREE Trial	$109M	-6.2x	1.7x
AVENUE THERAPEUTICS, INC.	ATXI	Unlock Forecast - 30 Days FREE Trial	$2M	-9.5x	0.4x
Astria Therapeutics, Inc.	ATXS	Unlock Forecast - 30 Days FREE Trial	$436M	-4.7x	1.7x
Aurinia Pharmaceuticals Inc.	AUPH	Unlock Forecast - 30 Days FREE Trial	$1719M	28.4x	5.1x
ArriVent BioPharma, Inc.	AVBP	Unlock Forecast - 30 Days FREE Trial	$757M	x	3.0x
AVADEL PHARMACEUTICALS PLC	AVDL	Unlock Forecast - 30 Days FREE Trial	$1505M	-10.2x	16.6x
Atea Pharmaceuticals, Inc.	AVIR	Unlock Forecast - 30 Days FREE Trial	$288M	-1.5x	0.7x
Jade Biosciences, Inc.	AVTE	Unlock Forecast - 30 Days FREE Trial	$2719M	-0.9x	36.2x
Avalo Therapeutics, Inc.	AVTX	Unlock Forecast - 30 Days FREE Trial	$68M	-0.1x	0.6x
Axsome Therapeutics, Inc.	AXSM	Unlock Forecast - 30 Days FREE Trial	$5500M	-19.9x	103.4x
AYTU BIOPHARMA, INC	AYTU	Unlock Forecast - 30 Days FREE Trial	$15M	-0.3x	0.4x
Azitra, Inc.	AZTR	Unlock Forecast - 30 Days FREE Trial	$4M	-0.2x	0.5x
BridgeBio Pharma, Inc.	BBIO	Unlock Forecast - 30 Days FREE Trial	$10323M	-11.6x	-5.4x
Bicara Therapeutics Inc.	BCAX	Unlock Forecast - 30 Days FREE Trial	$658M	x	1.5x
BriaCell Therapeutics Corp.	BCTX	Unlock Forecast - 30 Days FREE Trial	$50M	-1.7x	4.0x
BriaCell Therapeutics Corp.	BCTXW	Unlock Forecast - 30 Days FREE Trial	$4M	x	-2.5x
BICYCLE THERAPEUTICS PLC	BCYC	Unlock Forecast - 30 Days FREE Trial	$496M	-6.0x	0.7x
BeOne Medicines Ltd.	BEIGF	Unlock Forecast - 30 Days FREE Trial	$23196M	x	6.2x
BullFrog AI Holdings, Inc.	BFRG	Unlock Forecast - 30 Days FREE Trial	$11M	-2.9x	5.1x
BullFrog AI Holdings, Inc.	BFRGW	Unlock Forecast - 30 Days FREE Trial	$9M	x	2.4x
Biofrontera Inc.	BFRI	Unlock Forecast - 30 Days FREE Trial	$9M	-0.1x	17.9x
Biofrontera Inc.	BFRIW	Unlock Forecast - 30 Days FREE Trial	$1M	x	0.2x
BeiGene, Ltd.	BGNE	Unlock Forecast - 30 Days FREE Trial	$255876M	-454.6x	74.5x
Bausch Health Companies Inc.	BHC	Unlock Forecast - 30 Days FREE Trial	$-520M	-5.3x	-2.0x
Biohaven Ltd.	BHVN	Unlock Forecast - 30 Days FREE Trial	$1536M	-4.6x	11.4x
BioAge Labs, Inc.	BIOA	Unlock Forecast - 30 Days FREE Trial	$171M	x	0.6x
BIORA THERAPEUTICS, INC.	BIOR	Unlock Forecast - 30 Days FREE Trial	$1M	-0.1x	0.0x
BIOVIE INC.	BIVI	Unlock Forecast - 30 Days FREE Trial	$3M	-0.6x	0.2x
BELITE BIO, INC	BLTE	Unlock Forecast - 30 Days FREE Trial	$1942M	x	21.5x
Biomea Fusion, Inc.	BMEA	Unlock Forecast - 30 Days FREE Trial	$112M	-1.6x	4.1x
BIOMARIN PHARMACEUTICAL INC	BMRN	Unlock Forecast - 30 Days FREE Trial	$11087M	16.9x	1.8x
BRISTOL MYERS SQUIBB CO	BMY	Unlock Forecast - 30 Days FREE Trial	$95557M	18.9x	5.5x
BRISTOL MYERS SQUIBB CO	BMYMP	Unlock Forecast - 30 Days FREE Trial	$1606697M	318.2x	92.2x
Neuphoria Therapeutics Inc.	BNOX	Unlock Forecast - 30 Days FREE Trial	$13392M	x	784.5x
Benitec Biopharma Inc.	BNTC	Unlock Forecast - 30 Days FREE Trial	$265M	-0.6x	3.5x
Boundless Bio, Inc.	BOLD	Unlock Forecast - 30 Days FREE Trial	$26M	-15.1x	0.2x
Bolt Biotherapeutics, Inc.	BOLT	Unlock Forecast - 30 Days FREE Trial	$212M	-0.3x	4.5x
Blueprint Medicines Corp	BPMC	Unlock Forecast - 30 Days FREE Trial	$8361M	-32.3x	24.4x
BIO-PATH HOLDINGS, INC.	BPTH	Unlock Forecast - 30 Days FREE Trial	$1M	0.0x	-1.2x
Barinthus Biotherapeutics plc.	BRNS	Unlock Forecast - 30 Days FREE Trial	$60M	-0.6x	0.5x
BioXcel Therapeutics, Inc.	BTAI	Unlock Forecast - 30 Days FREE Trial	$12M	-0.1x	-0.1x
BeyondSpring Inc.	BYSI	Unlock Forecast - 30 Days FREE Trial	$46M	x	-3.1x
CalciMedica, Inc.	CALC	Unlock Forecast - 30 Days FREE Trial	$45M	0.4x	7.4x
Camp4 Therapeutics Corp	CAMP	Unlock Forecast - 30 Days FREE Trial	$31M	-0.1x	0.8x
Can-Fite BioPharma Ltd.	CANF	Unlock Forecast - 30 Days FREE Trial	$2579M	x	616.4x
CAPRICOR THERAPEUTICS, INC.	CAPR	Unlock Forecast - 30 Days FREE Trial	$327M	-14.1x	2.6x
Tvardi Therapeutics, Inc.	CARA	Unlock Forecast - 30 Days FREE Trial	$73M	-0.1x	-15.9x
Carisma Therapeutics Inc.	CARM	Unlock Forecast - 30 Days FREE Trial	$16M	-0.7x	114.0x
CASI Pharmaceuticals, Inc.	CASI	Unlock Forecast - 30 Days FREE Trial	$36M	-1.4x	19.6x
Perspective Therapeutics, Inc.	CATX	Unlock Forecast - 30 Days FREE Trial	$312M	-2.8x	1.1x
CRESCENT BIOPHARMA, INC.	CBIO	Unlock Forecast - 30 Days FREE Trial	$861M	-6.5x	255.1x
Avid Bioservices, Inc.	CDMO	Unlock Forecast - 30 Days FREE Trial	$799M	-6.6x	17.8x
CDT Equity Inc.	CDT	Unlock Forecast - 30 Days FREE Trial	$3M	-0.7x	0.8x
CONDUIT PHARMACEUTICALS INC.	CDTTW	Unlock Forecast - 30 Days FREE Trial	$2M	x	-0.2x
Celularity Inc	CELU	Unlock Forecast - 30 Days FREE Trial	$73M	-0.2x	8.2x
Celularity Inc	CELUW	Unlock Forecast - 30 Days FREE Trial	$1M	x	0.1x
Cingulate Inc.	CING	Unlock Forecast - 30 Days FREE Trial	$19M	-0.6x	3.5x
Cingulate Inc.	CINGW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Checkpoint Therapeutics, Inc.	CKPT	Unlock Forecast - 30 Days FREE Trial	$179M	-2.8x	-14.3x
Cell Source, Inc.	CLCS	Unlock Forecast - 30 Days FREE Trial	$18M	x	x
Clene Inc.	CLNN	Unlock Forecast - 30 Days FREE Trial	$57M	-7.3x	-6.9x
Clene Inc.	CLNNW	Unlock Forecast - 30 Days FREE Trial	$0M	x	-0.1x
Cellectar Biosciences, Inc.	CLRB	Unlock Forecast - 30 Days FREE Trial	$230M	-0.1x	27.9x
Clearside Biomedical, Inc.	CLSD	Unlock Forecast - 30 Days FREE Trial	$27M	-2.0x	-0.7x
Climb Bio, Inc.	CLYM	Unlock Forecast - 30 Days FREE Trial	$162M	-1.4x	0.9x
Chemomab Therapeutics Ltd.	CMMB	Unlock Forecast - 30 Days FREE Trial	$1421M	10.9x	146.5x
COMPASS Pathways plc	CMPS	Unlock Forecast - 30 Days FREE Trial	$471M	0.0x	2.9x
CHIMERIX INC	CMRX	Unlock Forecast - 30 Days FREE Trial	$801M	-3.1x	6.6x
CNS Pharmaceuticals, Inc.	CNSP	Unlock Forecast - 30 Days FREE Trial	$3M	0.0x	0.2x
Centessa Pharmaceuticals plc	CNTA	Unlock Forecast - 30 Days FREE Trial	$2623M	-11.0x	7.6x
Connect Biopharma Holdings Ltd	CNTB	Unlock Forecast - 30 Days FREE Trial	$97M	x	1.4x
Context Therapeutics Inc.	CNTX	Unlock Forecast - 30 Days FREE Trial	$78M	-1.5x	1.0x
Cocrystal Pharma, Inc.	COCP	Unlock Forecast - 30 Days FREE Trial	$17M	-1.0x	1.0x
Cogent Biosciences, Inc.	COGT	Unlock Forecast - 30 Days FREE Trial	$1474M	-3.7x	9.5x
COLLEGIUM PHARMACEUTICAL, INC	COLL	Unlock Forecast - 30 Days FREE Trial	$1003M	12.0x	4.3x
CORCEPT THERAPEUTICS INC	CORT	Unlock Forecast - 30 Days FREE Trial	$8233M	50.6x	12.1x
Coya Therapeutics, Inc.	COYA	Unlock Forecast - 30 Days FREE Trial	$105M	-6.8x	3.7x
CHINA PHARMA HOLDINGS, INC.	CPHI	Unlock Forecast - 30 Days FREE Trial	$5M	-0.2x	0.9x
CUMBERLAND PHARMACEUTICALS INC	CPIX	Unlock Forecast - 30 Days FREE Trial	$50M	-4.5x	1.8x
CATALYST PHARMACEUTICALS, INC.	CPRX	Unlock Forecast - 30 Days FREE Trial	$2569M	12.3x	3.0x
GELESIS HOLDINGS, INC.	CPSR	Unlock Forecast - 30 Days FREE Trial	$1568M	-39.0x	18.0x
Corbus Pharmaceuticals Holdings, Inc.	CRBP	Unlock Forecast - 30 Days FREE Trial	$104M	-2.0x	0.8x
CorMedix Inc.	CRMD	Unlock Forecast - 30 Days FREE Trial	$951M	18.6x	4.3x
Crinetics Pharmaceuticals, Inc.	CRNX	Unlock Forecast - 30 Days FREE Trial	$3308M	-15.9x	2.8x
CervoMed Inc.	CRVO	Unlock Forecast - 30 Days FREE Trial	$97M	-0.7x	2.9x
Corvus Pharmaceuticals, Inc.	CRVS	Unlock Forecast - 30 Days FREE Trial	$471M	-13.7x	5.9x
Catalent, Inc.	CTLT	Unlock Forecast - 30 Days FREE Trial	$11522M	-13.0x	3.3x
CytomX Therapeutics, Inc.	CTMX	Unlock Forecast - 30 Days FREE Trial	$248M	5.2x	2.1x
Contineum Therapeutics, Inc.	CTNM	Unlock Forecast - 30 Days FREE Trial	$34M	x	0.2x
CITIUS ONCOLOGY, INC.	CTOR	Unlock Forecast - 30 Days FREE Trial	$135M	3.9x	4.2x
Citius Pharmaceuticals, Inc.	CTXR	Unlock Forecast - 30 Days FREE Trial	$18M	-5.3x	0.3x
Cue Biopharma, Inc.	CUE	Unlock Forecast - 30 Days FREE Trial	$68M	-1.2x	10.3x
Cadrenal Therapeutics, Inc.	CVKD	Unlock Forecast - 30 Days FREE Trial	$27M	-11.1x	6.2x
CV Sciences, Inc.	CVSI	Unlock Forecast - 30 Days FREE Trial	$6M	x	3.1x
Cyclacel Pharmaceuticals, Inc.	CYCC	Unlock Forecast - 30 Days FREE Trial	$4658M	-0.1x	1521.1x
Cyclacel Pharmaceuticals, Inc.	CYCCP	Unlock Forecast - 30 Days FREE Trial	$1956M	-1.2x	638.9x
Cyclerion Therapeutics, Inc.	CYCN	Unlock Forecast - 30 Days FREE Trial	$11M	-5.2x	1.3x
CytoDyn Inc.	CYDY	Unlock Forecast - 30 Days FREE Trial	$400M	106.7x	x
Cryoport, Inc.	CYRX	Unlock Forecast - 30 Days FREE Trial	$520M	6.9x	1.0x
CYTOKINETICS INC	CYTK	Unlock Forecast - 30 Days FREE Trial	$6M	-9.4x	-13.9x
Dare Bioscience, Inc.	DARE	Unlock Forecast - 30 Days FREE Trial	$19M	2.9x	-2.3x
Day One Biopharmaceuticals, Inc.	DAWN	Unlock Forecast - 30 Days FREE Trial	$769M	-8.9x	1.7x
Denali Capital Acquisition Corp.	DECA	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Denali Capital Acquisition Corp.	DECAU	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Denali Capital Acquisition Corp.	DECAW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Journey Medical Corp	DERM	Unlock Forecast - 30 Days FREE Trial	$161M	24.1x	8.4x
DiaMedica Therapeutics Inc.	DMAC	Unlock Forecast - 30 Days FREE Trial	$264M	-4.2x	9.7x
Dianthus Therapeutics, Inc. /DE/	DNTH	Unlock Forecast - 30 Days FREE Trial	$656M	-3.2x	2.0x
Dermata Therapeutics, Inc.	DRMA	Unlock Forecast - 30 Days FREE Trial	$4M	-0.2x	0.7x
Dermata Therapeutics, Inc.	DRMAW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
DURECT CORP	DRRX	Unlock Forecast - 30 Days FREE Trial	$59M	-1.2x	17.0x
Design Therapeutics, Inc.	DSGN	Unlock Forecast - 30 Days FREE Trial	$226M	-7.6x	1.0x
DYNAVAX TECHNOLOGIES CORP	DVAX	Unlock Forecast - 30 Days FREE Trial	$1206M	88.2x	2.4x
Dogwood Therapeutics, Inc.	DWTX	Unlock Forecast - 30 Days FREE Trial	$112M	-2.9x	16.3x
Dyne Therapeutics, Inc.	DYN	Unlock Forecast - 30 Days FREE Trial	$1508M	-7.8x	2.6x
Emergent BioSolutions Inc.	EBS	Unlock Forecast - 30 Days FREE Trial	$426M	3.1x	0.8x
Edesa Biotech, Inc.	EDSA	Unlock Forecast - 30 Days FREE Trial	$8M	-1.3x	3.7x
EAGLE PHARMACEUTICALS, INC.	EGRX	Unlock Forecast - 30 Days FREE Trial	$42M	3.5x	0.2x
PMGC Holdings Inc.	ELAB	Unlock Forecast - 30 Days FREE Trial	$3M	-8.2x	0.4x
Elanco Animal Health Inc	ELAN	Unlock Forecast - 30 Days FREE Trial	$9517M	21.9x	1.4x
Eledon Pharmaceuticals, Inc.	ELDN	Unlock Forecast - 30 Days FREE Trial	$225M	-2.4x	2.0x
Elicio Therapeutics, Inc.	ELTX	Unlock Forecast - 30 Days FREE Trial	$149M	-1.9x	16.8x
Enliven Therapeutics, Inc.	ELVN	Unlock Forecast - 30 Days FREE Trial	$1210M	-13.3x	2.5x
Enlivex Therapeutics Ltd.	ENLV	Unlock Forecast - 30 Days FREE Trial	$25M	x	1.3x
Ensysce Biosciences, Inc.	ENSC	Unlock Forecast - 30 Days FREE Trial	$5M	-3.1x	1.7x
ENANTA PHARMACEUTICALS INC	ENTA	Unlock Forecast - 30 Days FREE Trial	$161M	-1.3x	1.7x
Entero Therapeutics, Inc.	ENTO	Unlock Forecast - 30 Days FREE Trial	$-113M	0.0x	0.3x
Enveric Biosciences, Inc.	ENVB	Unlock Forecast - 30 Days FREE Trial	$3M	-0.1x	0.8x
Evolus, Inc.	EOLS	Unlock Forecast - 30 Days FREE Trial	$593M	-13.1x	-89.8x
ESSA Pharma Inc.	EPIX	Unlock Forecast - 30 Days FREE Trial	$10M	-2.7x	0.1x
Equillium, Inc.	EQ	Unlock Forecast - 30 Days FREE Trial	$15M	-3.2x	1.4x
Erasca, Inc.	ERAS	Unlock Forecast - 30 Days FREE Trial	$440M	-3.1x	1.2x
Ernexa Therapeutics Inc.	ERNA	Unlock Forecast - 30 Days FREE Trial	$0M	-0.1x	-0.1x
Esperion Therapeutics, Inc.	ESPR	Unlock Forecast - 30 Days FREE Trial	$533M	-4.2x	-0.2x
89bio, Inc.	ETNB	Unlock Forecast - 30 Days FREE Trial	$1350M	-3.5x	2.6x
Eton Pharmaceuticals, Inc.	ETON	Unlock Forecast - 30 Days FREE Trial	$478M	-66.2x	20.0x
Evoke Pharma Inc	EVOK	Unlock Forecast - 30 Days FREE Trial	$7M	-1.8x	1.2x
Edgewise Therapeutics, Inc.	EWTX	Unlock Forecast - 30 Days FREE Trial	$1573M	-19.7x	2.7x
HYPERION DEFI, INC.	EYEN	Unlock Forecast - 30 Days FREE Trial	$46M	-0.1x	-4.7x
Fortress Biotech, Inc.	FBIO	Unlock Forecast - 30 Days FREE Trial	$7M	-0.2x	0.3x
Fortress Biotech, Inc.	FBIOP	Unlock Forecast - 30 Days FREE Trial	$26M	-0.6x	1.2x
FibroBiologics, Inc.	FBLG	Unlock Forecast - 30 Days FREE Trial	$22M	x	25.1x
Forte Biosciences, Inc.	FBRX	Unlock Forecast - 30 Days FREE Trial	$81M	-11.5x	2.1x
FIBROGEN INC	FGEN	Unlock Forecast - 30 Days FREE Trial	$38M	-0.2x	-3.6x
Foghorn Therapeutics Inc.	FHTX	Unlock Forecast - 30 Days FREE Trial	$363M	-3.3x	-5.5x
Flora Growth Corp.	FLGC	Unlock Forecast - 30 Days FREE Trial	$508M	-4.2x	126.2x
AMICUS THERAPEUTICS, INC.	FOLD	Unlock Forecast - 30 Days FREE Trial	$2420M	-8.5x	11.8x
Fulcrum Therapeutics, Inc.	FULC	Unlock Forecast - 30 Days FREE Trial	$479M	-36.1x	2.2x
GALECTIN THERAPEUTICS INC	GALT	Unlock Forecast - 30 Days FREE Trial	$290M	-2.4x	-1.6x
Gain Therapeutics, Inc.	GANX	Unlock Forecast - 30 Days FREE Trial	$47M	-1.4x	8.1x
Generation Bio Co.	GBIO	Unlock Forecast - 30 Days FREE Trial	$40M	-0.6x	0.8x
GERON CORP	GERN	Unlock Forecast - 30 Days FREE Trial	$968M	-11.9x	3.6x
Galmed Pharmaceuticals Ltd.	GLMD	Unlock Forecast - 30 Days FREE Trial	$M	x	x
Greenwich LifeSciences, Inc.	GLSI	Unlock Forecast - 30 Days FREE Trial	$147M	-17.2x	102.3x
Galecto, Inc.	GLTO	Unlock Forecast - 30 Days FREE Trial	$4M	-2.5x	0.4x
CRESCENT BIOPHARMA, INC.	GLYC	Unlock Forecast - 30 Days FREE Trial	$1013M	-0.5x	300.2x
GENELUX Corp	GNLX	Unlock Forecast - 30 Days FREE Trial	$126M	-2.8x	4.2x
Genprex, Inc.	GNPX	Unlock Forecast - 30 Days FREE Trial	$8M	-3.2x	2.0x
Gossamer Bio, Inc.	GOSS	Unlock Forecast - 30 Days FREE Trial	$386M	-3.2x	-61.8x
GeoVax Labs, Inc.	GOVX	Unlock Forecast - 30 Days FREE Trial	$12M	-0.8x	1.5x
GeoVax Labs, Inc.	GOVXW	Unlock Forecast - 30 Days FREE Trial	$1M	x	0.1x
Structure Therapeutics Inc.	GPCR	Unlock Forecast - 30 Days FREE Trial	$3672M	-44.0x	4.8x
Grace Therapeutics, Inc.	GRCE	Unlock Forecast - 30 Days FREE Trial	$51M	-3.9x	0.8x
GRI Bio, Inc.	GRI	Unlock Forecast - 30 Days FREE Trial	$4M	-0.1x	3.5x
Galera Therapeutics, Inc.	GRTX	Unlock Forecast - 30 Days FREE Trial	$2M	-0.3x	-0.1x
GT Biopharma, Inc.	GTBP	Unlock Forecast - 30 Days FREE Trial	$5M	-7.8x	-5.4x
GYRE THERAPEUTICS, INC.	GYRE	Unlock Forecast - 30 Days FREE Trial	$1102M	126.7x	12.0x
HUTCHMED (China) Ltd	HCM	Unlock Forecast - 30 Days FREE Trial	$14147M	x	11.5x
HCW Biologics Inc.	HCWB	Unlock Forecast - 30 Days FREE Trial	$0M	-0.4x	0.0x
Hepion Pharmaceuticals, Inc.	HEPA	Unlock Forecast - 30 Days FREE Trial	$1M	-0.1x	0.2x
Helix Acquisition Corp. II	HLXB	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
HUTCHMED (China) Ltd	HMDCF	Unlock Forecast - 30 Days FREE Trial	$2826M	x	2.3x
HOOKIPA Pharma Inc.	HOOK	Unlock Forecast - 30 Days FREE Trial	$12M	-1.0x	0.4x
Hoth Therapeutics, Inc.	HOTH	Unlock Forecast - 30 Days FREE Trial	$18M	-0.5x	1.8x
Werewolf Therapeutics, Inc.	HOWL	Unlock Forecast - 30 Days FREE Trial	$61M	-1.3x	1.5x
Harmony Biosciences Holdings, Inc.	HRMY	Unlock Forecast - 30 Days FREE Trial	$1929M	10.7x	2.5x
HARROW, INC.	HROW	Unlock Forecast - 30 Days FREE Trial	$1317M	-46.8x	23.3x
HARROW, INC.	HROWL	Unlock Forecast - 30 Days FREE Trial	$925M	-31.4x	16.4x
HARROW, INC.	HROWM	Unlock Forecast - 30 Days FREE Trial	$960M	-32.5x	17.0x
HERON THERAPEUTICS, INC. /DE/	HRTX	Unlock Forecast - 30 Days FREE Trial	$259M	-6.4x	-10.1x
TuHURA Biosciences, Inc./NV	HURA	Unlock Forecast - 30 Days FREE Trial	$114M	x	11.6x
HYPERION DEFI, INC.	HYPD	Unlock Forecast - 30 Days FREE Trial	$37M	x	-3.8x
iBio, Inc.	IBIO	Unlock Forecast - 30 Days FREE Trial	$17M	-0.4x	1.1x
IMPACT BIOMEDICAL INC.	IBO	Unlock Forecast - 30 Days FREE Trial	$10M	x	6.5x
IDEAYA Biosciences, Inc.	IDYA	Unlock Forecast - 30 Days FREE Trial	$1891M	-12.2x	1.9x
IGC Pharma, Inc.	IGC	Unlock Forecast - 30 Days FREE Trial	$36M	-4.6x	6.0x
IGM Biosciences, Inc.	IGMS	Unlock Forecast - 30 Days FREE Trial	$79M	-2.6x	0.8x
Immix Biopharma, Inc.	IMMX	Unlock Forecast - 30 Days FREE Trial	$83M	-2.8x	4.7x
Immunome Inc.	IMNM	Unlock Forecast - 30 Days FREE Trial	$915M	-2.4x	3.4x
Imunon, Inc.	IMNN	Unlock Forecast - 30 Days FREE Trial	$8M	-0.5x	17.8x
Enliven Therapeutics, Inc.	IMRA	Unlock Forecast - 30 Days FREE Trial	$2184M	-0.5x	4.5x
Immuneering Corp	IMRX	Unlock Forecast - 30 Days FREE Trial	$0M	-0.8x	0.0x
EOM Pharmaceutical Holdings, Inc.	IMUC	Unlock Forecast - 30 Days FREE Trial	$M	x	x
IMMUNIC, INC.	IMUX	Unlock Forecast - 30 Days FREE Trial	$96M	-0.8x	2.8x
Indaptus Therapeutics, Inc.	INDP	Unlock Forecast - 30 Days FREE Trial	$186M	-0.6x	66.4x
INDIVIOR PLC	INDV	Unlock Forecast - 30 Days FREE Trial	$3084M	x	x
InMed Pharmaceuticals Inc.	INM	Unlock Forecast - 30 Days FREE Trial	$3M	-51.8x	0.5x
INOVIO PHARMACEUTICALS, INC.	INO	Unlock Forecast - 30 Days FREE Trial	$108M	-0.6x	3.8x
INSMED Inc	INSM	Unlock Forecast - 30 Days FREE Trial	$30966M	-14.0x	24.8x
Innoviva, Inc.	INVA	Unlock Forecast - 30 Days FREE Trial	$1727M	44.7x	3.1x
Inozyme Pharma, Inc.	INZY	Unlock Forecast - 30 Days FREE Trial	$258M	-2.0x	8.1x
IO Biotech, Inc.	IOBT	Unlock Forecast - 30 Days FREE Trial	$128M	-0.7x	80.7x
IONIS PHARMACEUTICALS INC	IONS	Unlock Forecast - 30 Days FREE Trial	$9711M	-14.6x	15.4x
Opus Genetics, Inc.	IRD	Unlock Forecast - 30 Days FREE Trial	$76M	-2.0x	4.4x
Disc Medicine, Inc.	IRON	Unlock Forecast - 30 Days FREE Trial	$2188M	-18.4x	3.6x
IRONWOOD PHARMACEUTICALS INC	IRWD	Unlock Forecast - 30 Days FREE Trial	$182M	64.7x	-0.4x
International Stem Cell CORP	ISCO	Unlock Forecast - 30 Days FREE Trial	$0M	x	x
Intra-Cellular Therapies, Inc.	ITCI	Unlock Forecast - 30 Days FREE Trial	$14021M	-96.8x	12.2x
Iterum Therapeutics plc	ITRM	Unlock Forecast - 30 Days FREE Trial	$0M	-0.8x	0.0x
Incannex Healthcare Inc.	IXHL	Unlock Forecast - 30 Days FREE Trial	$10M	x	1.3x
Jaguar Health, Inc.	JAGX	Unlock Forecast - 30 Days FREE Trial	$0M	-0.2x	0.8x
Janux Therapeutics, Inc.	JANX	Unlock Forecast - 30 Days FREE Trial	$1483M	-63.7x	1.5x
Jazz Pharmaceuticals plc	JAZZ	Unlock Forecast - 30 Days FREE Trial	$7932M	14.3x	2.1x
Jade Biosciences, Inc.	JBIO	Unlock Forecast - 30 Days FREE Trial	$254M	x	1.3x
JOHNSON & JOHNSON	JNJ	Unlock Forecast - 30 Days FREE Trial	$431662M	19.1x	5.5x
JUPITER NEUROSCIENCES, INC.	JUNS	Unlock Forecast - 30 Days FREE Trial	$43M	x	32.0x
KALA BIO, Inc.	KALA	Unlock Forecast - 30 Days FREE Trial	$97M	-0.5x	6.5x
KalVista Pharmaceuticals, Inc.	KALV	Unlock Forecast - 30 Days FREE Trial	$800M	-2.6x	8.4x
Kairos Pharma, LTD.	KAPA	Unlock Forecast - 30 Days FREE Trial	$17M	x	2.4x
Kiniksa Pharmaceuticals International, plc	KNSA	Unlock Forecast - 30 Days FREE Trial	$0M	-64.7x	0.0x
KIORA PHARMACEUTICALS INC	KPRX	Unlock Forecast - 30 Days FREE Trial	$11M	-2.4x	0.5x
Karyopharm Therapeutics Inc.	KPTI	Unlock Forecast - 30 Days FREE Trial	$57M	-0.6x	-0.2x
Kronos Bio, Inc.	KRON	Unlock Forecast - 30 Days FREE Trial	$54M	-0.6x	0.7x
Keros Therapeutics, Inc.	KROS	Unlock Forecast - 30 Days FREE Trial	$558M	-13.3x	0.8x
Korro Bio, Inc.	KRRO	Unlock Forecast - 30 Days FREE Trial	$128M	-7.9x	1.6x
Pasithea Therapeutics Corp.	KTTA	Unlock Forecast - 30 Days FREE Trial	$5M	-73.5x	0.4x
Pasithea Therapeutics Corp.	KTTAW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Kura Oncology, Inc.	KURA	Unlock Forecast - 30 Days FREE Trial	$719M	-4.5x	2.4x
Kezar Life Sciences, Inc.	KZR	Unlock Forecast - 30 Days FREE Trial	$30M	-3.2x	0.3x
Longboard Pharmaceuticals, Inc.	LBPH	Unlock Forecast - 30 Days FREE Trial	$2342M	-27.9x	8.5x
Lexaria Bioscience Corp.	LEXX	Unlock Forecast - 30 Days FREE Trial	$19M	-29.3x	3.4x
Lexaria Bioscience Corp.	LEXXW	Unlock Forecast - 30 Days FREE Trial	$4M	x	0.5x
LIFECORE BIOMEDICAL, INC. \DE\	LFCR	Unlock Forecast - 30 Days FREE Trial	$298M	-5.1x	133.6x
Lifevantage Corp	LFVN	Unlock Forecast - 30 Days FREE Trial	$163M	54.8x	4.8x
LIGAND PHARMACEUTICALS INC	LGND	Unlock Forecast - 30 Days FREE Trial	$2684M	65.6x	3.4x
Longeveron Inc.	LGVN	Unlock Forecast - 30 Days FREE Trial	$0M	-0.5x	0.0x
LianBio	LIANY	Unlock Forecast - 30 Days FREE Trial	$7M	x	0.0x
LFTD PARTNERS INC.	LIFD	Unlock Forecast - 30 Days FREE Trial	$4M	x	0.1x
LIPELLA PHARMACEUTICALS INC.	LIPO	Unlock Forecast - 30 Days FREE Trial	$3M	-3.3x	1.0x
LIXTE BIOTECHNOLOGY HOLDINGS, INC.	LIXT	Unlock Forecast - 30 Days FREE Trial	$11M	-0.9x	9.4x
LIXTE BIOTECHNOLOGY HOLDINGS, INC.	LIXTW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.4x
ELI LILLY & Co	LLY	Unlock Forecast - 30 Days FREE Trial	$667697M	48.4x	36.5x
Lipocine Inc.	LPCN	Unlock Forecast - 30 Days FREE Trial	$17M	-2.6x	0.9x
LEAP THERAPEUTICS, INC.	LPTX	Unlock Forecast - 30 Days FREE Trial	$14M	-1.1x	0.7x
Liquidia Corp	LQDA	Unlock Forecast - 30 Days FREE Trial	$2385M	-7.2x	157.0x
Larimar Therapeutics, Inc.	LRMR	Unlock Forecast - 30 Days FREE Trial	$206M	-0.8x	1.4x
LISATA THERAPEUTICS, INC.	LSTA	Unlock Forecast - 30 Days FREE Trial	$18M	-1.0x	0.9x
Lantern Pharma Inc.	LTRN	Unlock Forecast - 30 Days FREE Trial	$46M	-2.4x	3.7x
LUMOS PHARMA, INC.	LUMO	Unlock Forecast - 30 Days FREE Trial	$38M	-1.0x	7.6x
LAVA Therapeutics NV	LVTX	Unlock Forecast - 30 Days FREE Trial	$42M	x	2.1x
LEXICON PHARMACEUTICALS, INC.	LXRX	Unlock Forecast - 30 Days FREE Trial	$0M	-1.2x	0.0x
Lyell Immunopharma, Inc.	LYEL	Unlock Forecast - 30 Days FREE Trial	$180M	-1.1x	0.6x
MAIA Biotechnology, Inc.	MAIA	Unlock Forecast - 30 Days FREE Trial	$49M	-1.4x	12.6x
MUSTANG BIO, INC.	MBIO	Unlock Forecast - 30 Days FREE Trial	$5M	-0.1x	1.6x
Moleculin Biotech, Inc.	MBRX	Unlock Forecast - 30 Days FREE Trial	$11M	-2.3x	269.8x
MBX Biosciences, Inc.	MBX	Unlock Forecast - 30 Days FREE Trial	$388M	x	1.8x
Seres Therapeutics, Inc.	MCRB	Unlock Forecast - 30 Days FREE Trial	$123M	-1.0x	2.4x
Medicus Pharma Ltd.	MDCX	Unlock Forecast - 30 Days FREE Trial	$30M	x	x
Medicus Pharma Ltd.	MDCXW	Unlock Forecast - 30 Days FREE Trial	$40M	x	x
MADRIGAL PHARMACEUTICALS, INC.	MDGL	Unlock Forecast - 30 Days FREE Trial	$10084M	-5.7x	14.5x
23andMe Holding Co.	ME	Unlock Forecast - 30 Days FREE Trial	$0M	-4.6x	0.0x
MEI Pharma, Inc.	MEIP	Unlock Forecast - 30 Days FREE Trial	$39M	16.6x	2.0x
MACROGENICS INC	MGNX	Unlock Forecast - 30 Days FREE Trial	$126M	-2.1x	2.7x
MIRA PHARMACEUTICALS, INC.	MIRA	Unlock Forecast - 30 Days FREE Trial	$24M	-1.6x	42.7x
Mirum Pharmaceuticals, Inc.	MIRM	Unlock Forecast - 30 Days FREE Trial	$3874M	-20.0x	15.2x
Milestone Pharmaceuticals Inc.	MIST	Unlock Forecast - 30 Days FREE Trial	$96M	-2.0x	4.2x
MoonLake Immunotherapeutics	MLTX	Unlock Forecast - 30 Days FREE Trial	$3912M	-50.8x	11.1x
Mineralys Therapeutics, Inc.	MLYS	Unlock Forecast - 30 Days FREE Trial	$2444M	-4.5x	7.8x
MANNKIND CORP	MNKD	Unlock Forecast - 30 Days FREE Trial	$1768M	53.9x	-20.2x
MEDICINOVA INC	MNOV	Unlock Forecast - 30 Days FREE Trial	$60M	-7.1x	1.2x
Monopar Therapeutics	MNPR	Unlock Forecast - 30 Days FREE Trial	$289M	-3.0x	5.4x
Mereo BioPharma Group plc	MREO	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Merck & Co., Inc.	MRK	Unlock Forecast - 30 Days FREE Trial	$0M	17.5x	0.0x
Marker Therapeutics, Inc.	MRKR	Unlock Forecast - 30 Days FREE Trial	$11M	-0.6x	1.0x
MARINUS PHARMACEUTICALS, INC.	MRNS	Unlock Forecast - 30 Days FREE Trial	$30M	-0.1x	-0.5x
Mersana Therapeutics, Inc.	MRSN	Unlock Forecast - 30 Days FREE Trial	$35M	-3.4x	-1.4x
Merus N.V.	MRUS	Unlock Forecast - 30 Days FREE Trial	$5077M	-13.5x	6.0x
MARAVAI LIFESCIENCES HOLDINGS, INC.	MRVI	Unlock Forecast - 30 Days FREE Trial	$635M	-5.6x	2.4x
Molecular Templates, Inc.	MTEM	Unlock Forecast - 30 Days FREE Trial	$3M	1.7x	0.4x
Matinas BioPharma Holdings, Inc.	MTNB	Unlock Forecast - 30 Days FREE Trial	$3M	-1.7x	0.2x
Metsera, Inc.	MTSR	Unlock Forecast - 30 Days FREE Trial	$3682M	x	8.2x
MetaVia Inc.	MTVA	Unlock Forecast - 30 Days FREE Trial	$17M	-0.5x	1.7x
Mural Oncology plc	MURA	Unlock Forecast - 30 Days FREE Trial	$36M	x	0.6x
NewAmsterdam Pharma Co N.V.	NAMS	Unlock Forecast - 30 Days FREE Trial	$2989M	x	3.8x
NewAmsterdam Pharma Co N.V.	NAMSW	Unlock Forecast - 30 Days FREE Trial	$1818M	x	2.3x
NATURES SUNSHINE PRODUCTS INC	NATR	Unlock Forecast - 30 Days FREE Trial	$335M	23.8x	2.1x
NovaBay Pharmaceuticals, Inc.	NBY	Unlock Forecast - 30 Days FREE Trial	$4M	-1.8x	0.6x
Endo LP	NDOI	Unlock Forecast - 30 Days FREE Trial	$1798M	x	1.6x
Minerva Neurosciences, Inc.	NERV	Unlock Forecast - 30 Days FREE Trial	$14M	-0.8x	-0.5x
Neuphoria Therapeutics Inc.	NEUP	Unlock Forecast - 30 Days FREE Trial	$24M	x	0.9x
Neurogene Inc.	NGNE	Unlock Forecast - 30 Days FREE Trial	$419M	-7.3x	1.5x
NIKA PHARMACEUTICALS, INC	NIKA	Unlock Forecast - 30 Days FREE Trial	$983M	x	x
NEKTAR THERAPEUTICS	NKTR	Unlock Forecast - 30 Days FREE Trial	$566M	-1.2x	337.9x
Nkarta, Inc.	NKTX	Unlock Forecast - 30 Days FREE Trial	$167M	-1.3x	0.5x
NLS Pharmaceutics Ltd.	NLSP	Unlock Forecast - 30 Days FREE Trial	$14M	x	25.2x
NLS Pharmaceutics Ltd.	NLSPW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.2x
NANOVIRICIDES, INC.	NNVC	Unlock Forecast - 30 Days FREE Trial	$28M	-2.1x	2.8x
MetaVia Inc.	NRBO	Unlock Forecast - 30 Days FREE Trial	$20M	-0.5x	1.5x
Nurix Therapeutics, Inc.	NRIX	Unlock Forecast - 30 Days FREE Trial	$830M	-7.4x	1.9x
NeuroSense Therapeutics Ltd.	NRSN	Unlock Forecast - 30 Days FREE Trial	$30M	x	x
NRX Pharmaceuticals, Inc.	NRXP	Unlock Forecast - 30 Days FREE Trial	$52M	-0.6x	-2.1x
NRX Pharmaceuticals, Inc.	NRXPW	Unlock Forecast - 30 Days FREE Trial	$1M	x	0.0x
NEONC TECHNOLOGIES HOLDINGS, INC.	NTHI	Unlock Forecast - 30 Days FREE Trial	$153M	x	x
Nuvation Bio Inc.	NUVB	Unlock Forecast - 30 Days FREE Trial	$783M	-1.2x	1.9x
Nuvalent, Inc.	NUVL	Unlock Forecast - 30 Days FREE Trial	$5726M	-30.9x	6.1x
Nuvectis Pharma, Inc.	NVCT	Unlock Forecast - 30 Days FREE Trial	$160M	-3.9x	9.5x
NORTHWEST BIOTHERAPEUTICS INC	NWBO	Unlock Forecast - 30 Days FREE Trial	$315M	x	x
NEXIEN BIOPHARMA, INC.	NXEN	Unlock Forecast - 30 Days FREE Trial	$1M	x	x
NextCure, Inc.	NXTC	Unlock Forecast - 30 Days FREE Trial	$140M	-0.5x	2.5x
Ocean Biomedical, Inc.	OCEA	Unlock Forecast - 30 Days FREE Trial	$1M	-0.3x	0.0x
Ocean Biomedical, Inc.	OCEAW	Unlock Forecast - 30 Days FREE Trial	$1M	x	0.0x
OCULAR THERAPEUTIX, INC	OCUL	Unlock Forecast - 30 Days FREE Trial	$2212M	-8.2x	7.2x
ORAGENICS INC	OGEN	Unlock Forecast - 30 Days FREE Trial	$126M	-0.1x	917.2x
Organon & Co.	OGN	Unlock Forecast - 30 Days FREE Trial	$2748M	3.9x	3.8x
OnKure Therapeutics, Inc.	OKUR	Unlock Forecast - 30 Days FREE Trial	$37M	-6.9x	0.5x
Olema Pharmaceuticals, Inc.	OLMA	Unlock Forecast - 30 Days FREE Trial	$710M	-4.0x	2.1x
OMEROS CORP	OMER	Unlock Forecast - 30 Days FREE Trial	$197M	-4.2x	-0.9x
BeOne Medicines Ltd.	ONC	Unlock Forecast - 30 Days FREE Trial	$503841M	x	133.6x
Onconetix, Inc.	ONCO	Unlock Forecast - 30 Days FREE Trial	$153M	-0.3x	17.9x
Oncternal Therapeutics, Inc.	ONCT	Unlock Forecast - 30 Days FREE Trial	$2M	0.0x	0.2x
OPKO HEALTH, INC.	OPK	Unlock Forecast - 30 Days FREE Trial	$473M	-3.5x	0.3x
OptiNose, Inc.	OPTN	Unlock Forecast - 30 Days FREE Trial	$97M	-1.5x	-1.6x
Organogenesis Holdings Inc.	ORGO	Unlock Forecast - 30 Days FREE Trial	$554M	-32.9x	2.3x
Oric Pharmaceuticals, Inc.	ORIC	Unlock Forecast - 30 Days FREE Trial	$943M	-4.2x	2.9x
Oruka Therapeutics, Inc.	ORKA	Unlock Forecast - 30 Days FREE Trial	$544M	x	1.5x
ORAMED PHARMACEUTICALS INC.	ORMP	Unlock Forecast - 30 Days FREE Trial	$87M	21.9x	0.6x
OS Therapies Inc	OSTX	Unlock Forecast - 30 Days FREE Trial	$89M	x	18.0x
Oncotelic Therapeutics, Inc.	OTLC	Unlock Forecast - 30 Days FREE Trial	$18M	x	2.2x
Ovid Therapeutics Inc.	OVID	Unlock Forecast - 30 Days FREE Trial	$87M	-2.6x	1.6x
One World Products, Inc.	OWPC	Unlock Forecast - 30 Days FREE Trial	$2M	x	x
PHIBRO ANIMAL HEALTH CORP	PAHC	Unlock Forecast - 30 Days FREE Trial	$1657M	34.3x	5.8x
Prestige Consumer Healthcare Inc.	PBH	Unlock Forecast - 30 Days FREE Trial	$3262M	15.3x	1.8x
PUMA BIOTECHNOLOGY, INC.	PBYI	Unlock Forecast - 30 Days FREE Trial	$252M	5.2x	2.4x
Pacira BioSciences, Inc.	PCRX	Unlock Forecast - 30 Days FREE Trial	$1032M	-7534.1x	1.3x
Processa Pharmaceuticals, Inc.	PCSA	Unlock Forecast - 30 Days FREE Trial	$2M	-0.5x	0.5x
PDS Biotechnology Corp	PDSB	Unlock Forecast - 30 Days FREE Trial	$56M	-1.7x	3.5x
PepGen Inc.	PEPG	Unlock Forecast - 30 Days FREE Trial	$46M	-1.6x	0.6x
PFIZER INC	PFE	Unlock Forecast - 30 Days FREE Trial	$140632M	13.1x	1.6x
PRECIGEN, INC.	PGEN	Unlock Forecast - 30 Days FREE Trial	$520M	-1.4x	-37.0x
Phathom Pharmaceuticals, Inc.	PHAT	Unlock Forecast - 30 Days FREE Trial	$891M	-1.6x	-1.6x
Phio Pharmaceuticals Corp.	PHIO	Unlock Forecast - 30 Days FREE Trial	$12M	-0.8x	1.0x
PALVELLA THERAPEUTICS, INC.	PIRS	Unlock Forecast - 30 Days FREE Trial	$0M	-5.1x	0.0x
PLIANT THERAPEUTICS, INC.	PLRX	Unlock Forecast - 30 Days FREE Trial	$88M	-4.5x	0.3x
Polomar Health Services, Inc.	PMHS	Unlock Forecast - 30 Days FREE Trial	$6M	x	0.7x
ProMIS Neurosciences Inc.	PMN	Unlock Forecast - 30 Days FREE Trial	$15M	-2.1x	2.1x
PMV Pharmaceuticals, Inc.	PMVP	Unlock Forecast - 30 Days FREE Trial	$77M	-1.6x	0.6x
Propanc Biopharma, Inc.	PPCB	Unlock Forecast - 30 Days FREE Trial	$25M	x	1.4x
Praxis Precision Medicines, Inc.	PRAX	Unlock Forecast - 30 Days FREE Trial	$996M	-4.0x	2.5x
PAINREFORM LTD.	PRFX	Unlock Forecast - 30 Days FREE Trial	$6M	x	x
PERRIGO Co plc	PRGO	Unlock Forecast - 30 Days FREE Trial	$3706M	-27.6x	0.9x
Prelude Therapeutics Inc	PRLD	Unlock Forecast - 30 Days FREE Trial	$0M	-0.5x	0.0x
ProPhase Labs, Inc.	PRPH	Unlock Forecast - 30 Days FREE Trial	$15M	-0.5x	1.0x
PROTHENA CORP PUBLIC LTD CO	PRTA	Unlock Forecast - 30 Days FREE Trial	$348M	-12.4x	0.8x
PTC THERAPEUTICS, INC.	PTCT	Unlock Forecast - 30 Days FREE Trial	$4926M	7.8x	-20.3x
Protagonist Therapeutics, Inc	PTGX	Unlock Forecast - 30 Days FREE Trial	$3553M	68.3x	5.3x
Protagenic Therapeutics, Inc.\new	PTIX	Unlock Forecast - 30 Days FREE Trial	$2M	-2.8x	-22.8x
PALATIN TECHNOLOGIES INC	PTN	Unlock Forecast - 30 Days FREE Trial	$4M	-11.9x	-0.6x
Petros Pharmaceuticals, Inc.	PTPI	Unlock Forecast - 30 Days FREE Trial	$1M	-0.1x	-0.1x
Pulmatrix, Inc.	PULM	Unlock Forecast - 30 Days FREE Trial	$23M	-1.8x	3.2x
PROVECTUS BIOPHARMACEUTICALS, INC.	PVCT	Unlock Forecast - 30 Days FREE Trial	$31M	x	x
PALVELLA THERAPEUTICS, INC.	PVLA	Unlock Forecast - 30 Days FREE Trial	$327M	x	5.9x
Aspire Biopharma Holdings, Inc.	PWUP	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Aspire Biopharma Holdings, Inc.	PWUPU	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Aspire Biopharma Holdings, Inc.	PWUPW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Pyxis Oncology, Inc.	PYXS	Unlock Forecast - 30 Days FREE Trial	$70M	-1.3x	0.7x
Qualigen Therapeutics, Inc.	QLGN	Unlock Forecast - 30 Days FREE Trial	$5M	-1.3x	-1.1x
Quoin Pharmaceuticals, Ltd.	QNRX	Unlock Forecast - 30 Days FREE Trial	$156M	x	61.0x
Q32 Bio Inc.	QTTB	Unlock Forecast - 30 Days FREE Trial	$27M	-0.7x	-6.7x
uniQure N.V.	QURE	Unlock Forecast - 30 Days FREE Trial	$821M	-2.8x	24.4x
Rani Therapeutics Holdings, Inc.	RANI	Unlock Forecast - 30 Days FREE Trial	$0M	-1.3x	0.0x
Rapport Therapeutics, Inc.	RAPP	Unlock Forecast - 30 Days FREE Trial	$524M	x	2.0x
RAPT Therapeutics, Inc.	RAPT	Unlock Forecast - 30 Days FREE Trial	$155M	-0.4x	0.9x
Ultragenyx Pharmaceutical Inc.	RARE	Unlock Forecast - 30 Days FREE Trial	$2487M	-7.0x	17.2x
ROCKET PHARMACEUTICALS, INC.	RCKT	Unlock Forecast - 30 Days FREE Trial	$328M	-4.8x	0.8x
ROCKET PHARMACEUTICALS, INC.	RCKTW	Unlock Forecast - 30 Days FREE Trial	$6M	x	0.0x
Arcus Biosciences, Inc.	RCUS	Unlock Forecast - 30 Days FREE Trial	$969M	-5.5x	1.8x
REGENERON PHARMACEUTICALS, INC.	REGN	Unlock Forecast - 30 Days FREE Trial	$61373M	13.8x	2.1x
RENOVARO INC.	RENB	Unlock Forecast - 30 Days FREE Trial	$55M	-0.9x	0.6x
REVELATION BIOSCIENCES, INC.	REVB	Unlock Forecast - 30 Days FREE Trial	$4M	-0.1x	1.2x
REVELATION BIOSCIENCES, INC.	REVBW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
Rafael Holdings, Inc.	RFL	Unlock Forecast - 30 Days FREE Trial	$38M	-0.9x	0.5x
Regulus Therapeutics Inc.	RGLS	Unlock Forecast - 30 Days FREE Trial	$565M	3.2x	8.2x
RIGEL PHARMACEUTICALS INC	RIGL	Unlock Forecast - 30 Days FREE Trial	$751M	7.7x	9.2x
RELMADA THERAPEUTICS, INC.	RLMD	Unlock Forecast - 30 Days FREE Trial	$19M	-0.1x	0.9x
Rallybio Corp	RLYB	Unlock Forecast - 30 Days FREE Trial	$27M	-0.7x	0.6x
ROCKWELL MEDICAL, INC.	RMTI	Unlock Forecast - 30 Days FREE Trial	$56M	-17.1x	1.8x
Avidity Biosciences, Inc.	RNA	Unlock Forecast - 30 Days FREE Trial	$6219M	-12.2x	5.2x
Cartesian Therapeutics, Inc.	RNAC	Unlock Forecast - 30 Days FREE Trial	$277M	-2.1x	-14.1x
Transcode Therapeutics, Inc.	RNAZ	Unlock Forecast - 30 Days FREE Trial	$9M	-0.2x	1.5x
Rein Therapeutics, Inc.	RNTX	Unlock Forecast - 30 Days FREE Trial	$31M	x	0.6x
RenovoRx, Inc.	RNXT	Unlock Forecast - 30 Days FREE Trial	$45M	-3.4x	4.3x
Roivant Sciences Ltd.	ROIV	Unlock Forecast - 30 Days FREE Trial	$9761M	1.8x	2.3x
Royalty Pharma plc	RPRX	Unlock Forecast - 30 Days FREE Trial	$30557M	29.9x	4.8x
Repare Therapeutics Inc.	RPTX	Unlock Forecast - 30 Days FREE Trial	$73M	-2.1x	0.7x
ReShape Lifesciences Inc.	RSLS	Unlock Forecast - 30 Days FREE Trial	$2M	-3.7x	1.9x
Rapid Therapeutic Science Laboratories, Inc.	RTSL	Unlock Forecast - 30 Days FREE Trial	$0M	0.5x	x
Revance Therapeutics, Inc.	RVNC	Unlock Forecast - 30 Days FREE Trial	$383M	-1.0x	-2.4x
REVIVA PHARMACEUTICALS HOLDINGS, INC.	RVPH	Unlock Forecast - 30 Days FREE Trial	$30M	-4.1x	-4.3x
REVIVA PHARMACEUTICALS HOLDINGS, INC.	RVPHW	Unlock Forecast - 30 Days FREE Trial	$5M	x	-0.5x
RHYTHM PHARMACEUTICALS, INC.	RYTM	Unlock Forecast - 30 Days FREE Trial	$-71532M	-20.3x	2603.1x
Rezolute, Inc.	RZLT	Unlock Forecast - 30 Days FREE Trial	$559M	-3.9x	6.8x
Sage Therapeutics, Inc.	SAGE	Unlock Forecast - 30 Days FREE Trial	$544M	-1.2x	1.5x
CASSAVA SCIENCES INC	SAVA	Unlock Forecast - 30 Days FREE Trial	$104M	-1.9x	1.2x
Sunshine Biopharma Inc.	SBFM	Unlock Forecast - 30 Days FREE Trial	$4M	-0.6x	0.2x
Sunshine Biopharma Inc.	SBFMW	Unlock Forecast - 30 Days FREE Trial	$1M	x	0.0x
Scienture Holdings, Inc.	SCNX	Unlock Forecast - 30 Days FREE Trial	$14M	2.9x	0.2x
scPharmaceuticals Inc.	SCPH	Unlock Forecast - 30 Days FREE Trial	$299M	-2.0x	-50.9x
Scorpius Holdings, Inc.	SCPX	Unlock Forecast - 30 Days FREE Trial	$1M	0.0x	0.0x
SCYNEXIS INC	SCYX	Unlock Forecast - 30 Days FREE Trial	$44M	-2.4x	1.0x
Schrodinger, Inc.	SDGR	Unlock Forecast - 30 Days FREE Trial	$1418M	-7.8x	4.1x
Septerna, Inc.	SEPN	Unlock Forecast - 30 Days FREE Trial	$654M	x	1.7x
Serina Therapeutics, Inc.	SER	Unlock Forecast - 30 Days FREE Trial	$47M	22.6x	26.2x
Sagimet Biosciences Inc.	SGMT	Unlock Forecast - 30 Days FREE Trial	$281M	x	2.0x
Shuttle Pharmaceuticals Holdings, Inc.	SHPH	Unlock Forecast - 30 Days FREE Trial	$1M	-0.5x	0.4x
SIGA TECHNOLOGIES INC	SIGA	Unlock Forecast - 30 Days FREE Trial	$472M	8.0x	2.2x
Silo Pharma, Inc.	SILO	Unlock Forecast - 30 Days FREE Trial	$3M	-1.4x	0.7x
Sionna Therapeutics, Inc.	SION	Unlock Forecast - 30 Days FREE Trial	$1104M	x	3.3x
Skye Bioscience, Inc.	SKYE	Unlock Forecast - 30 Days FREE Trial	$159M	-0.7x	3.6x
Sol-Gel Technologies Ltd.	SLGL	Unlock Forecast - 30 Days FREE Trial	$78M	x	2.4x
Silence Therapeutics plc	SLN	Unlock Forecast - 30 Days FREE Trial	$806M	x	8.6x
Silence Therapeutics plc	SLNCF	Unlock Forecast - 30 Days FREE Trial	$227M	x	2.4x
ACELYRIN, Inc.	SLRN	Unlock Forecast - 30 Days FREE Trial	$229M	-23.5x	0.6x
Salarius Pharmaceuticals, Inc.	SLRX	Unlock Forecast - 30 Days FREE Trial	$1M	-0.5x	21.2x
SELLAS Life Sciences Group, Inc.	SLS	Unlock Forecast - 30 Days FREE Trial	$177M	-1.0x	6.4x
Summit Therapeutics Inc.	SMMT	Unlock Forecast - 30 Days FREE Trial	$19562M	104.1x	56.8x
Syndax Pharmaceuticals Inc	SNDX	Unlock Forecast - 30 Days FREE Trial	$1372M	-4.1x	8.7x
SOLIGENIX, INC.	SNGX	Unlock Forecast - 30 Days FREE Trial	$4M	-1.8x	1.2x
Sibannac, Inc.	SNNC	Unlock Forecast - 30 Days FREE Trial	$0M	x	x
TAO Synergies Inc.	SNPX	Unlock Forecast - 30 Days FREE Trial	$13M	4.2x	2.5x
Sensei Biotherapeutics, Inc.	SNSE	Unlock Forecast - 30 Days FREE Trial	$10M	-0.4x	0.4x
Sonnet BioTherapeutics Holdings, Inc.	SONN	Unlock Forecast - 30 Days FREE Trial	$20M	-1.6x	29.5x
SPRUCE BIOSCIENCES, INC.	SPRB	Unlock Forecast - 30 Days FREE Trial	$3M	-0.4x	0.1x
Spero Therapeutics, Inc.	SPRO	Unlock Forecast - 30 Days FREE Trial	$121M	-17.8x	3.7x
ARS Pharmaceuticals, Inc.	SPRY	Unlock Forecast - 30 Days FREE Trial	$1760M	-23.5x	7.7x
Sarepta Therapeutics, Inc.	SRPT	Unlock Forecast - 30 Days FREE Trial	$1723M	162.5x	1.3x
Stoke Therapeutics, Inc.	STOK	Unlock Forecast - 30 Days FREE Trial	$1332M	25.4x	4.0x
Shattuck Labs, Inc.	STTK	Unlock Forecast - 30 Days FREE Trial	$36M	-0.7x	0.5x
SUPERNUS PHARMACEUTICALS, INC.	SUPN	Unlock Forecast - 30 Days FREE Trial	$2588M	40.1x	2.4x
Savara Inc	SVRA	Unlock Forecast - 30 Days FREE Trial	$462M	-8.2x	2.3x
60 DEGREES PHARMACEUTICALS, INC.	SXTP	Unlock Forecast - 30 Days FREE Trial	$2M	-0.6x	0.8x
60 DEGREES PHARMACEUTICALS, INC.	SXTPW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0.0x
SYNLOGIC, INC.	SYBX	Unlock Forecast - 30 Days FREE Trial	$20M	-0.2x	1.5x
Spyre Therapeutics, Inc.	SYRE	Unlock Forecast - 30 Days FREE Trial	$1019M	-0.7x	2.1x
Syros Pharmaceuticals, Inc.	SYRS	Unlock Forecast - 30 Days FREE Trial	$5M	-0.1x	-0.4x
Theravance Biopharma, Inc.	TBPH	Unlock Forecast - 30 Days FREE Trial	$707M	54.3x	3.2x
Alaunos Therapeutics, Inc.	TCRT	Unlock Forecast - 30 Days FREE Trial	$4M	-1.0x	1.2x
Telomir Pharmaceuticals, Inc.	TELO	Unlock Forecast - 30 Days FREE Trial	$38M	x	78.6x
TENAX THERAPEUTICS, INC.	TENX	Unlock Forecast - 30 Days FREE Trial	$25M	-14.9x	0.2x
Terns Pharmaceuticals, Inc.	TERN	Unlock Forecast - 30 Days FREE Trial	$661M	-5.1x	2.2x
TEVA PHARMACEUTICAL INDUSTRIES LTD	TEVA	Unlock Forecast - 30 Days FREE Trial	$22392M	-13.9x	3.3x
TEVA PHARMACEUTICAL INDUSTRIES LTD	TEVJF	Unlock Forecast - 30 Days FREE Trial	$16614M	x	2.4x
TFF Pharmaceuticals, Inc.	TFFP	Unlock Forecast - 30 Days FREE Trial	$0M	0.0x	0.1x
TG THERAPEUTICS, INC.	TGTX	Unlock Forecast - 30 Days FREE Trial	$5263M	87.1x	19.0x
Tharimmune, Inc.	THAR	Unlock Forecast - 30 Days FREE Trial	$4M	-0.6x	-5.4x
Third Harmonic Bio, Inc.	THRD	Unlock Forecast - 30 Days FREE Trial	$242M	9.6x	0.9x
TALPHERA, INC.	TLPH	Unlock Forecast - 30 Days FREE Trial	$8M	-2.3x	1.5x
Tango Therapeutics, Inc.	TNGX	Unlock Forecast - 30 Days FREE Trial	$769M	-2.8x	5.7x
Tonix Pharmaceuticals Holding Corp.	TNXP	Unlock Forecast - 30 Days FREE Trial	$200M	0.0x	1.2x
Theriva Biologics, Inc.	TOVX	Unlock Forecast - 30 Days FREE Trial	$4M	-0.4x	0.1x
Tempest Therapeutics, Inc.	TPST	Unlock Forecast - 30 Days FREE Trial	$23M	-0.5x	2.1x
Traws Pharma, Inc.	TRAW	Unlock Forecast - 30 Days FREE Trial	$9M	-0.6x	1.4x
Entrada Therapeutics, Inc.	TRDA	Unlock Forecast - 30 Days FREE Trial	$215M	6.9x	0.6x
Trevi Therapeutics, Inc.	TRVI	Unlock Forecast - 30 Days FREE Trial	$869M	-6.1x	4.4x
2seventy bio, Inc.	TSVT	Unlock Forecast - 30 Days FREE Trial	$266M	-1.4x	1.2x
Tvardi Therapeutics, Inc.	TVRD	Unlock Forecast - 30 Days FREE Trial	$36M	x	-28.5x
Travere Therapeutics, Inc.	TVTX	Unlock Forecast - 30 Days FREE Trial	$1431M	-8.0x	43.6x
TherapeuticsMD, Inc.	TXMD	Unlock Forecast - 30 Days FREE Trial	$13M	-2.2x	0.5x
Tyra Biosciences, Inc.	TYRA	Unlock Forecast - 30 Days FREE Trial	$713M	-9.5x	2.4x
Unity Biotechnology, Inc.	UBX	Unlock Forecast - 30 Days FREE Trial	$2M	-0.5x	-8.7x
Unicycive Therapeutics, Inc.	UNCY	Unlock Forecast - 30 Days FREE Trial	$587M	-0.9x	52.1x
Upstream Bio, Inc.	UPB	Unlock Forecast - 30 Days FREE Trial	$970M	x	2.4x
UroGen Pharma Ltd.	URGN	Unlock Forecast - 30 Days FREE Trial	$872M	-2.5x	-15.2x
UNITED THERAPEUTICS Corp	UTHR	Unlock Forecast - 30 Days FREE Trial	$19139M	15.4x	2.7x
VACCINEX, INC.	VCNX	Unlock Forecast - 30 Days FREE Trial	$3M	-0.1x	1.4x
Vera Therapeutics, Inc.	VERA	Unlock Forecast - 30 Days FREE Trial	$1589M	-20.4x	3.4x
VERU INC.	VERU	Unlock Forecast - 30 Days FREE Trial	$89M	-0.8x	4.3x
Verve Therapeutics, Inc.	VERV	Unlock Forecast - 30 Days FREE Trial	$973M	-2.5x	2.1x
Vincerx Pharma, Inc.	VINC	Unlock Forecast - 30 Days FREE Trial	$0M	-0.2x	0.1x
Viracta Therapeutics, Inc.	VIRX	Unlock Forecast - 30 Days FREE Trial	$1M	-0.2x	-0.1x
Viking Therapeutics, Inc.	VKTX	Unlock Forecast - 30 Days FREE Trial	$3602M	-67.5x	4.3x
Vanda Pharmaceuticals Inc.	VNDA	Unlock Forecast - 30 Days FREE Trial	$272M	-16.1x	0.6x
Verrica Pharmaceuticals Inc.	VRCA	Unlock Forecast - 30 Days FREE Trial	$48M	-0.5x	-4.1x
Viridian Therapeutics, Inc.\DE	VRDN	Unlock Forecast - 30 Days FREE Trial	$1391M	-4.5x	2.3x
Vireo Growth Inc.	VREOF	Unlock Forecast - 30 Days FREE Trial	$226M	x	0.8x
Verona Pharma plc	VRNA	Unlock Forecast - 30 Days FREE Trial	$73127M	-185.1x	262.8x
Virpax Pharmaceuticals, Inc.	VRPX	Unlock Forecast - 30 Days FREE Trial	$0M	0.0x	-19.5x
VERTEX PHARMACEUTICALS INC / MA	VRTX	Unlock Forecast - 30 Days FREE Trial	$102449M	28.2x	6.0x
Verastem, Inc.	VSTM	Unlock Forecast - 30 Days FREE Trial	$284M	-6.5x	-8.7x
Vistagen Therapeutics, Inc.	VTGN	Unlock Forecast - 30 Days FREE Trial	$113M	-0.1x	2.0x
Viatris Inc	VTRS	Unlock Forecast - 30 Days FREE Trial	$0M	-29.5x	0.0x
vTv Therapeutics Inc.	VTVT	Unlock Forecast - 30 Days FREE Trial	$0M	-3.3x	-7.5x
Ventyx Biosciences, Inc.	VTYX	Unlock Forecast - 30 Days FREE Trial	$180M	-1.0x	0.9x
VYNE Therapeutics Inc.	VYNE	Unlock Forecast - 30 Days FREE Trial	$13M	-0.4x	0.3x
Whitehawk Therapeutics, Inc.	WHWK	Unlock Forecast - 30 Days FREE Trial	$100M	x	0.6x
Wave Life Sciences Ltd.	WVE	Unlock Forecast - 30 Days FREE Trial	$1285M	-22.2x	7.5x
Xenetic Biosciences, Inc.	XBIO	Unlock Forecast - 30 Days FREE Trial	$6M	-1.4x	1.1x
XBiotech Inc.	XBIT	Unlock Forecast - 30 Days FREE Trial	$89M	-3.5x	0.5x
EXICURE, INC.	XCUR	Unlock Forecast - 30 Days FREE Trial	$49M	-1.9x	4.3x
Xenon Pharmaceuticals Inc.	XENE	Unlock Forecast - 30 Days FREE Trial	$2424M	-15.4x	3.4x
Xeris Biopharma Holdings, Inc.	XERS	Unlock Forecast - 30 Days FREE Trial	$1266M	328.1x	-23.8x
Xilio Therapeutics, Inc.	XLO	Unlock Forecast - 30 Days FREE Trial	$120M	-0.5x	17.0x
Xencor Inc	XNCR	Unlock Forecast - 30 Days FREE Trial	$638M	-8.4x	1.0x
XOMA Royalty Corp	XOMA	Unlock Forecast - 30 Days FREE Trial	$800M	-11.7x	11.0x
XOMA Royalty Corp	XOMAO	Unlock Forecast - 30 Days FREE Trial	$579M	-10.1x	8.0x
XOMA Royalty Corp	XOMAP	Unlock Forecast - 30 Days FREE Trial	$607M	-10.5x	8.4x
Y-mAbs Therapeutics, Inc.	YMAB	Unlock Forecast - 30 Days FREE Trial	$195M	-16.9x	2.2x
Zenas BioPharma, Inc.	ZBIO	Unlock Forecast - 30 Days FREE Trial	$906M	x	3.8x
Zai Lab Ltd	ZLAB	Unlock Forecast - 30 Days FREE Trial	$34435M	-95.2x	43.5x
Zentalis Pharmaceuticals, Inc.	ZNTL	Unlock Forecast - 30 Days FREE Trial	$101M	-1.4x	0.3x
Zomedica Corp.	ZOM	Unlock Forecast - 30 Days FREE Trial	$122M	-2.6x	0.6x
Zomedica Corp.	ZOMDF	Unlock Forecast - 30 Days FREE Trial	$78M	x	0.6x
Zoetis Inc.	ZTS	Unlock Forecast - 30 Days FREE Trial	$67787M	26.0x	13.6x
ZEVRA THERAPEUTICS, INC.	ZVRA	Unlock Forecast - 30 Days FREE Trial	$660M	-55.3x	16.1x
ZyVersa Therapeutics, Inc.	ZVSA	Unlock Forecast - 30 Days FREE Trial	$1M	-0.1x	0.1x
Zymeworks Inc.	ZYME	Unlock Forecast - 30 Days FREE Trial	$1133M	-8.3x	3.4x

Frequently Asked Questions - CAPRICOR THERAPEUTICS, INC. Stock Forecast

How accurate are CAPRICOR THERAPEUTICS, INC. stock predictions?

Our AI model demonstrates 3% historical accuracy for CAPR predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence CAPRICOR THERAPEUTICS, INC. stock price forecasts?

Our analysis considers CAPRICOR THERAPEUTICS, INC.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is CAPRICOR THERAPEUTICS, INC. a good investment in 2025?

Based on our AI analysis, CAPRICOR THERAPEUTICS, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are CAPRICOR THERAPEUTICS, INC. forecasts updated?

CAPRICOR THERAPEUTICS, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced CAPRICOR THERAPEUTICS, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CAPRICOR THERAPEUTICS, INC. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...

Cookie Settings

Welcome !

CAPRICOR THERAPEUTICS, INC. (CAPR) AI Stock Price Forecast & Investment Analysis ⛶Full Screen

CAPRICOR THERAPEUTICS, INC. Stock Price Chart and Technical Analysis